In this live webcast, recent clinical evidence on NOACs/DOACs in patients with both AF and VTE were summarized.
Latest frontiers in anticoagulation therapy Prof. John Eikelboom discusses current choices of OACs and management of patients who receive a NOAC
Latest frontiers in anticoagulation therapy Prof. John Eikelboom discusses the indications for reversal of anticoagulation and results of trials with the available reversal agents.
Latest frontiers in anticoagulation therapy Prof. John Eikelboom summarizes results from COMPASS / Hokusai VTE Cancer trials and discusses the implications for clinical practice.
Latest frontiers in anticoagulation therapy Prof. John Eikelboom summarizes results from RE-CIRCUIT / RE-DUAL PCI trials and discusses the implications for clinical practice.